| Literature DB >> 30766611 |
Amanda Mara Teles1,2, Taynan Dulce da Silva Rosa3, Adenilde Nascimento Mouchrek1, Ana Lucia Abreu-Silva3, Kátia da Silva Calabrese4, Fernando Almeida-Souza3,4.
Abstract
The resistance mechanisms of bacteria and protozoans have evidenced the need of discover new compounds with potential pharmaceutical activity against pathogenic microorganisms. Medicinal plants have been for centuries a promising alternative as sources of new drugs. The objective of this work was to evaluate the chemical composition, antimicrobial and antileishmanial activities of Cinnamomum zeylanicum, Origanum vulgare, and Curcuma longa essential oils. Chemical analysis was performed by gas chromatography-mass spectrometry. Antimicrobial activity was performed by disk diffusion and minimum inhibitory concentration (MIC) test. Antileishmanial activity was performed against antipromastigote and intracellular amastigote of Leishmania amazonensis. Cytotoxic and nitrite production were realized in BALB/c peritoneal macrophages. The major compounds of the essential oils were cinnamic aldehyde (46.30%) in C. zeylanicum, cis-p-menth-2-en-1-ol (33.88%) and linalyl acetate (13.90%) in O. vulgare, and turmerone (55.43%) in C. longa. The MIC showed significant antimicrobial activity of C. longa essential oil against S. aureus (83.3 ± 14.43 µg/mL). Antipromastigote activity showed IC50 values >500 µg/mL to C. zeylanicum, 308.4 ± 1.402 µg/mL to O. vulgare, and 405.5 ± 1.119 µg/mL to C. longa essential oil. Activity against intracellular amastigote of L. amazonensis showed IC50 of 63.3 ± 1.369 µg/mL and cytotoxic was not observed, resulting in selectivity index higher than 15.79 to parasite. C. longa essential oil decreased nitrite production in peritoneal macrophages, but not in Leishmania-infected cells. The chemical composition of the three essential oils is directly associated to its potential biological action, as the antimicrobial activity. C. longa presented a potent antileishmanial activity against promastigote and intracellular amastigote of L. amazonensis, although this activity is not linked to nitric oxide, since C. longa essential oil inhibits its production.Entities:
Year: 2019 PMID: 30766611 PMCID: PMC6350612 DOI: 10.1155/2019/2421695
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Compounds identified in essential oils from leafs of Cinnamomum zeylanicum, Curcuma longa, and Origanum vulgare by CG-MS.
|
|
|
|
| ||||||
|
|
| % |
|
| % |
|
| % | |
|
| |||||||||
| 1 | 3.207 |
| 1.47 | 5.464 |
| 1.15 | 3.221 |
| 0.80 |
| 2 | 3.618 | Benzaldehyde | 4.16 | 5.638 | Myrcene | 0.37 | 3.733 | Bicyclo[3.1.0]hexane | 1.73 |
| 3 | 6.568 | 3-phenylpropionaldehyde | 2.95 | 6.823 | Vinyl propionate | 0.20 | 4.330 | (+)-4-Carene | 3.08 |
| 4 | 6.748 | Borneol | 1.06 | 7.206 | p-Cymene | 1.01 | 4.469 | p-Cymene | 8.29 |
| 5 | 7.077 |
| 0.87 | 7.206 | Bisabolone | 0.55 | 4.533 | Cyclohexene | 1.23 |
| 6 | 8.459 | Cinnamic Aldehyde | 46.30 | 8.304 |
| 12.02 | 4.561 |
| 2.73 |
| 7 | 9.593 | 3-Phenyl-1-propanol | 1.46 | 8.385 | 1,8-cineole | 1.01 | 4.954 | p-Menth-2-en-1-ol | 4.62 |
| 8 | 9.744 |
| 16.35 | 8.461 | Camphor | 1.24 | 5.171 | 1,4-cyclohexadiene | 1.21 |
| 9 | 10.346 | trans- | 8.26 | 9.267 |
| 4.13 | 5.361 | cis-Sabinene hydrate | 1.29 |
| 10 | 10.669 | (e)-cinnamyl acetate | 7.54 | 9.645 | Terpinolene | 0.43 | 5.598 | Terpinolene | 3.11 |
| 11 | 10.809 |
| 2.16 | 10.167 |
| 0.29 | 5.651 | 1,6-octadien-3-ol | 5.69 |
| 12 | 11.593 | delta-cadienene | 1.42 | 10.587 |
| 2.67 | 5.996 | trans-Sabinene hydrate | 1.59 |
| 13 | 12.422 | (-)-Spathulenol | 2.09 | 12.945 |
| 1.00 | 6.877 | cis-p-Menth-2-en-1-ol | 33.88 |
| 14 | 12.481 | Caryophyllene oxide | 2.80 | 13.544 |
| 6.96 | 7.079 | 3-Cyclohexen-1-ol | 5.26 |
| 15 | 14.645 | benzyl benzoate | 1.12 | 14.397 | ar-Curcumene | 1.58 | 7.669 | (+)- | 2.61 |
| 16 | – | – | – | 16.664 | Turmerone | 55.43 | 7.817 | Carvacrol methyl ether | 0.94 |
| 17 | – | – | – | 16.739 |
| 1.10 | 8.543 | Linalyl acetate | 13.90 |
| 18 | – | – | – | – | – | – | 10.307 | Thymol | 2.41 |
| 19 | – | – | – | – | – | – | 12.400 | trans- | 2.46 |
| 20 | – | – | – | – | – | – | 22.115 | 1H-Cycloprop(E)azulen-7-ol | 3.16 |
a: peak number according to the order of column elution. b: retention time (minutes) of the compounds in column. c: percentage of normalized area which indicates the relative distribution of the compounds in the sample.
Figure 1Chromatograms of Cinnamomum zeylanicum (a), Curcuma longa (b), and Origanum vulgare (c) essential oils.
Diameters of inhibition zones and minimum inhibitory concentration of different bacteria culture after 24 hours of treatment with Cinnamomum zeylanicum, Curcuma longa, or Origanum vulgare essential oil.
| Compounds | Bacteria strain | |||
|
|
|
| ||
|
| ||||
| Inhibition zones (mm) |
| 15.00 ± 1.000 | 14.67 ± 0.577 | 10.33 ± 0.577 |
|
| 12.67 ± 0.577 | 15.33 ± 0.577 | 9.66 ± 0.577 | |
|
| 14.67 ± 0.577 | 15.67 ± 0.577 | 12.00 ± 1.000 | |
| gentamycin | 14.33 ± 0.577 | 20.67 ± 0.577 | 16.67 ± 0.577 | |
|
| ||||
| MIC ( |
| 133.3 ± 14.43 | 216.7 ± 28.87 | 550.0 ± 0.00 |
|
| 216.7 ± 28.87 | 83.3 ± 14.43 | 383.3 ± 57.74 | |
|
| 266.7 ± 28.87 | 166.7 ± 28.87 | 483.3 ± 28.87 | |
| amoxicillin | 16.0 ± 0.00 | 8.0 ± 0.00 | n.d. | |
| gentamycin | n.d. | 2.0 ± 0.00 | n.d. | |
| polymyxin B | n.d. | n.d. | 16.0 ± 0.00 | |
To determine the inhibition zones, 75μL of each essential oil was used in the disk diffusion test. n.d.: not determined. Data represents mean ± standard deviation of experiment realized in triplicate.
Antileishmanial activity against Leishmania amazonensis and cytotoxicity against BALB/c peritoneal macrophages of Cinnamomum zeylanicum, Curcuma longa, and Origanum vulgare essential oils.
| Essential oils/ compounds |
| Cytotoxicity CC50 | SI | |
| Promastigote ( | Intracellular amastigote ( | Peritoneal macrophage ( | ||
|
| ||||
|
| >500 a,b,c | n.d. | >1000 | n.d. |
|
| 308.4 ± 1.402 a,d,e | 63.3 ± 1.369 a | >1000 | >15.79 |
|
| 405.5 ± 1.119 b,d,f | n.d. | >1000 | n.d. |
| Amphotericin B | 0.764 ± 0.139 c,e,f | 1.045 ± 0.145 a | 37.22 ± 1.834 | 35.6 |
Data represents mean ± standard deviation of at least two experiments realized in triplicate. CC50: cytotoxic concentration for 50% of cells; IC50: inhibitory concentration for 50% of parasites; SI: selectivity index; n.d.: not determined. Equal letters in the same column mean statistical difference between IC50 (p<0.0001) by one-way ANOVA and Tukey's multiple comparisons test.
Figure 2Viability of Leishmania amazonensis promastigotes treated for 72 hours with Cinnamomum zeylanicum, Curcuma longa, and Origanum vulgare essential oils.
Figure 3Infection parameters of BALB/c peritoneal macrophages infected with Leishmania amazonensis and treated with Curcuma longa essential oil. Data represent mean ± standard deviation of two independent experiments realized in triplicate. ∗p<0.05 and ∗∗p<0.01 when compared with the untreated group by Kruskal-Wallis followed by Dunn's multiple comparisons test.
Figure 4BALB/c peritoneal macrophages infected with Leishmania amazonensis and treated with Curcuma longa essential oil at 125 µg/mL for 24 hours. (a) Untreated infected macrophages. (b) Treatment decreased intracellular amastigote number and induced loss of intracellular amastigote integrity (red arrow). Images are representative of two experiments realized in triplicate. Giemsa, 40x objective.
Figure 5Nitrite quantification in supernatant of BALB/c peritoneal macrophage treated with Curcuma longa (400 µg/mL) and stimulated or not with Leishmania amazonensis. Data represents media ± standard deviation of experiment realized in sextuplicate; ∗p<0.05 when compared with untreated and unstimulated macrophage by Kruskal–Wallis and Dunn's multiple comparison test.